X-110198591-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015365.3(AMMECR1):c.931G>A(p.Ala311Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000313 in 1,201,291 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 133 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00022 ( 0 hom., 10 hem., cov: 23)
Exomes 𝑓: 0.00032 ( 0 hom. 123 hem. )
Consequence
AMMECR1
NM_015365.3 missense
NM_015365.3 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 5.70
Genes affected
AMMECR1 (HGNC:467): (AMMECR nuclear protein 1) The exact function of this gene is not known, however, submicroscopic deletion of the X chromosome including this gene, COL4A5, and FACL4 genes, result in a contiguous gene deletion syndrome, the AMME complex (Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.072279245).
BS2
High Hemizygotes in GnomAd4 at 10 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMMECR1 | NM_015365.3 | c.931G>A | p.Ala311Thr | missense_variant | 6/6 | ENST00000262844.10 | NP_056180.1 | |
AMMECR1 | NM_001025580.2 | c.820G>A | p.Ala274Thr | missense_variant | 5/5 | NP_001020751.1 | ||
AMMECR1 | NM_001171689.2 | c.562G>A | p.Ala188Thr | missense_variant | 8/8 | NP_001165160.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMMECR1 | ENST00000262844.10 | c.931G>A | p.Ala311Thr | missense_variant | 6/6 | 1 | NM_015365.3 | ENSP00000262844.5 |
Frequencies
GnomAD3 genomes AF: 0.000215 AC: 24AN: 111571Hom.: 0 Cov.: 23 AF XY: 0.000296 AC XY: 10AN XY: 33801
GnomAD3 genomes
AF:
AC:
24
AN:
111571
Hom.:
Cov.:
23
AF XY:
AC XY:
10
AN XY:
33801
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000133 AC: 23AN: 172346Hom.: 0 AF XY: 0.000121 AC XY: 7AN XY: 57948
GnomAD3 exomes
AF:
AC:
23
AN:
172346
Hom.:
AF XY:
AC XY:
7
AN XY:
57948
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000323 AC: 352AN: 1089668Hom.: 0 Cov.: 28 AF XY: 0.000345 AC XY: 123AN XY: 356124
GnomAD4 exome
AF:
AC:
352
AN:
1089668
Hom.:
Cov.:
28
AF XY:
AC XY:
123
AN XY:
356124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000215 AC: 24AN: 111623Hom.: 0 Cov.: 23 AF XY: 0.000295 AC XY: 10AN XY: 33863
GnomAD4 genome
AF:
AC:
24
AN:
111623
Hom.:
Cov.:
23
AF XY:
AC XY:
10
AN XY:
33863
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
15
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.931G>A (p.A311T) alteration is located in exon 6 (coding exon 6) of the AMMECR1 gene. This alteration results from a G to A substitution at nucleotide position 931, causing the alanine (A) at amino acid position 311 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;P;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at